These results agree with previous studies reporting a comparable incidence for the amplification of the entire 3q26 region in precancerous cervical lesions and cervical cancer [41], suggesting that the SEC62 gene harbors an oncogenic function. This evidence concerns the gene SEC62 and cervical cancer.